TRANSFORMING GROWTH FACTOR-ΒETA 1 AN EARLY PREDICTOR OF DIABETIC NEPHROPATHY
Journal Title: WORLD JOURNAL PHARMACY AND PHARMACEUTICAL SCIENCE - Year 2017, Vol 6, Issue 10
Abstract
Objectives: The common complication of diabetes is nephropathy which is a leading cause of renal failure in one third of patients undergoing dialysis. Transforming growth factor-beta 1 (TGF-β1) plays a crucial role in the progression of diabetic nephropathy. The present study aimed to evaluate if serum TGF-β1concentrations has any diagnostic role in predicting the incidence of diabetic nephropathy in the Pakistani patients before nephropathy starts. Patients and Methods: The study was performed on 140 subjects including normal, type 2 diabetes patients with and without proteinuria, and type 1 diabetes patients without proteinuria. Serum level of TGF-β1 was estimated by ELISA technique. Results: The mean serum level of TGF-β1estimated in the normal subjects was 507.28 ± 33.52 pg/mL. In comparison to normal, the TGF-β1 in type 2 diabetes with or without proteinuria and type 1 samples was significantly found to be elevated i.e., 1869.65 ± 238.59 pg/mL (P < 0.002), 1899.20 ± 211.03 pg/mL (P < 0.001), and 2866.91 ± 460.56 pg/mL (P < 0.001) respectively. Statistical analysis revealed no significant difference between type 2 diabetes with and without proteinuria, however, the type 1 diabetes samples reflect significant difference from type 2 samples with (P < 0.03) and without proteinuria (P < 0.04). Conclusion: Increased serum TGF-1 in diabetes samples with or without proteinuria suggest that it can serve as a predictive marker of diabetic nephropathy in diabetic patients before they suffer from chronic renal failure or diabetic nephropathy.
Authors and Affiliations
Dr. Mehwish Subhan
Keywords
Related Articles
- EP ID EP618668
- DOI -
- Views 129
- Downloads 0
TARGETING OF ANTI CANCER DRUGS THROUGH NANOPARTICLES
studies suggested that nanoparticle drug delivery might improve the therapeutic response to anticancer drugs and allow the simultaneous monitoring of drug uptake by tumours. Cancer Nano therapeutics are rapidly progressi...
CORRELATION BETWEEN HYPOTHYROIDISM AND IRON DEFICIENCY ANEMIA IN FEMALE PATIENTS
Iron deficiency anemia is a frequent clinical condition accompanying thyroid dysfunction including hypothyroidism, the hormones of Thyroid can be effect directly of blood formation especially red blood cells by enhanceme...
TOPIC ALOE VERA AS AN ALTERNATIVE TREATMENT TO PATIENTS WITH CHRONIC VENOUS ULCER
Chronic venous ulcer affects seventy to ninety percent of the patients with valvular insufficiency. This disease may be hereditary or not, causing prolonged health problems. As a chronic disease, its treatment is longer...
A NOVEL APPROACH IN THE TREATMENT OF ORAL CANCER- GENE THERAPY AN UPDATE
Gene therapy “the use of genes as medicine” involves the transfer of a therapeutic or working copy of a gene into specific cells of an individual in order to repair a faulty gene copy. Many experiments have been done wit...
GENETIC VARIATION AND POLYMORPHISM IDENTIFICATION IN MICE TREATED WITH TRAMADOL AND TRAMACET USING AFLP FINGERPRINTING "COMPARATIVE STUDY"
Tramadol and tramadol/ acetaminophen (tramacet) as a centrally acting analgesic are commonly prescribed as effective in treatment of acute and chronic moderate to severe pain. The present study was established to investi...